Article
Methotrexate
17 Apr 2012
Abstract excerpt
Previously established as a chemotherapeutic agent for decades, methotrexate has been adapted for use as a medical therapy for unruptured ectopic pregnancies. Its mechanism of action, competitive inhibition of folate-dependent steps in nucleic acid synthesis, effectively kills the rapidly dividing ectopic trophoblast. However, the same action on normal cells is the basis for many of its adverse effects.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
